Literature DB >> 6788952

Altered drug binding to serum proteins in pregnant women: therapeutic relevance.

E Perucca, M Ruprah, A Richens.   

Abstract

The binding of diazepam, phenytoin and valproic acid to serum proteins in vitro has been compared in pregnant women of different gestational ages and in controls. The unbound fraction of each of three drugs was elevated during pregnancy (particularly during the last 8 weeks) probably due, at least in part, to a fall in serum albumin concentration. These findings may provide a partial explanation for the increase in the clearance of certain drugs during pregnancy and need to be taken into account when interpreting serum drug levels in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788952      PMCID: PMC1438765          DOI: 10.1177/014107688107400606

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  12 in total

1.  Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors:  P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

2.  Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease.

Authors:  W D Hooper; F Bochner; M J Eadie; J H Tyrer
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

3.  Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.

Authors:  J MacGee
Journal:  Anal Chem       Date:  1970-03       Impact factor: 6.986

4.  Albumin standards and the measurement of serum albumin with bromcresol green.

Authors:  B T Doumas; W A Watson; H G Biggs
Journal:  Clin Chim Acta       Date:  1971-01       Impact factor: 3.786

Review 5.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

6.  Phenytoin and phenobarbitone plasma clearance during pregnancy.

Authors:  K I Mygind; M Dam; J Christiansen
Journal:  Acta Neurol Scand       Date:  1976-08       Impact factor: 3.209

7.  Antiepileptic drugs: metabolism in pregnancy.

Authors:  M Dam; J Christiansen; O Munck; K I Mygind
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

8.  Serum protein binding of drugs and bilirubin in newborn infants and their mothers.

Authors:  C Hamar; G Levy
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

Review 9.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

10.  Serum protein binding of drugs during and after pregnancy in rats.

Authors:  B Stock; M Dean; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1980-02       Impact factor: 4.030

View more
  11 in total

Review 1.  Plasma protein binding of drugs in pregnancy and in neonates.

Authors:  L J Notarianni
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 2.  Plasma protein binding of drugs in pregnancy.

Authors:  E Perucca; A Crema
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 3.  Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.

Authors:  H Nau; W Kuhnz; H J Egger; D Rating; H Helge
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

4.  Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy.

Authors:  S S Chen; E Perucca; J N Lee; A Richens
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

5.  Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

6.  A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.

Authors:  André Dallmann; Ibrahim Ince; Katrin Coboeken; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

7.  Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.

Authors:  André Dallmann; Ibrahim Ince; Juri Solodenko; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

8.  Differential transplacental binding of valproic acid: influence of free fatty acids.

Authors:  F Albani; R Riva; M Contin; A Baruzzi; M Altomare; G P Merlini; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

Review 9.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

10.  The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin.

Authors:  R G Dickinson; W D Hooper; B Wood; C M Lander; M J Eadie
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.